Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Crystal Amber plots more payouts; Orcadian fundraise

Fri, 01st Jul 2022 21:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Crystal Amber Fund Ltd - Guernsey-based investment company - Expects to return further 10 pence per share by mid-August and additional 60p per share by end of September. "If these distributions can be achieved, this would bring total returns in the first nine months of 2022 to 80p a share," Crystal Amber says.

----------

Orcadian Energy PLC - North Sea focused oil and gas development company - Raises GBP1 million through placing of 2.9 million shares at 35 pence each. Cash will go towards licence fees and for general working capital purposes.

----------

Ncondezi Energy Ltd - Mozambique-based power development company - Says restructuring talks in regard to working capital facility term loan with Seritza Ltd "progressing well" and to be finalised "imminently". "Whilst the principle terms are finalised Seritza has confirmed that it will extend the period in which it will not call in the loan to 8 July 2022," Ncondezi says.

----------

East Star Resources PLC - gold and copper exploration company focused on Kazakhstan - Says "multiple mineralised quartz veins" spotted from rock chip samples at Dalny licence on Chu-Ili gold belt in central Kazakhstan. "All quartz vein samples contained gold mineralisation," East Star says.

----------

Bradda Head Lithium Ltd - North America-focused lithium development company - Says results from initial scout drilling programme at Wikieup asset "demonstrate the presence of lithium bearing clays". Chief Executive Charles FitzRoy adds: "Further work is required, but these results are positive and will help in the planning our future programmes there." The project is located halfway between Phoenix and Las Vegas in US.

----------

Artemis Resources Ltd - Perth-based miner with gold, copper and cobalt projects in Australia - Says maiden drill programme planned at Osborne nickel sulphide target underway.

----------

Cornish Metals Inc - Vancouver-based mineral exploration company - Reports assay results from diamond drill holes designed to test Trenares Lode target at United Downs project in Cornwall, UK. Says "multiple zones of mineralisation" intersected at each drill section. Mineralisation is principally "tin - zinc - silver with minor copper".

----------

Hummingbird Resources PLC - gold production, development and exploration focused on West Africa - Says company reserves up "materially" to 4.1 million ounces of gold from 1.1 million ounces reported in November. Resources up 8% to 7.3 million ounces of gold. Updates reserves and resources estimate includes maiden ore reserve at Kinkine deposit, higher-grade ore reserves at the Koekoe deposit and maiden reserves for Dugbe in Liberia.

----------

Open Orphan PLC - London-based pharmaceutical services - Says hVIVO unit is developing the world's first Omicron human challenge model. hVIVO signs deal with Nasdaq-listed Vaxart Inc to develop model to conduct Omicron human challenge study in 2023. Test will test efficacy of Vaxart's oral vaccine candidate, VXA-CoV2-1. "To develop the model, hVIVO will manufacture a new SARS-CoV-2 challenge agent based on the Omicron variant. The Good Manufacturing Practice compliant virus manufacturing activities will commence immediately and are expected to complete by Q4 2022," Open Orphan adds.

----------

Pharma C Investments PLC - New Jersey-based early-stage investor in the medical cannabis industry - Raises GBP200,000 through subscription of 80 million new shares at 0.25 pence each. "The proceeds of the subscription will be used to provide the company with additional working capital," Pharma C says.

----------

Schroder Real Estate Investment Trust Ltd - UK-focused real estate investment trust - Disposes of 26,975 square feet single let industrial asset in Portsmouth for GBP6.5 million. Sales price ops GBP4.9 million March 31 independent valuation. "Further disposals are under consideration, alongside potential acquisitions of adjoining ownerships where these support delivery of the asset business plan," company adds. Since March 31, completes 17 new letting, renewals and review, which will generate additional GBP2.7 million of annual rent and increase contracted rental income by GBP1.0 million per year.

----------

Riverstone Credit Opportunities Income PLC - aims to generate returns by making loans to companies in energy sector - Says realises investment in Roaring Fork Midstream at over 21% internal rate of return. In March of last year, Riverstone had committed USD5.9 million for first lien delayed-draw term loan to sponsor-backed Roaring Fork Midstream. Roaring Fork owns and operates pipeline and storage related infrastructure moving natural gas and oil from the wellhead to market.

----------

Mobile Streams PLC - London-based mobile content provider - Extends contract with International Gaming Systems for additional six months starting July. "The revenue share contract will see the two companies continue to undertake various joint projects in the areas of Esports, gaming and digital merchandise," Mobile Streams adds.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
9 Mar 2021 14:31

IN BRIEF: Open Orphan wins new contract with Oxford BioTherapeutics

IN BRIEF: Open Orphan wins new contract with Oxford BioTherapeutics

Read more
9 Mar 2021 11:38

Open Orphan subsidiary awarded contract with Oxford BioTherapeutics

(Sharecast News) - Specialist pharmaceuticals contract research organisation Open Orphan announced on Tuesday that its subsidiary Venn Life Sciences had been awarded a contract for a study with clinical-stage oncology company Oxford BioTherapeutics.

Read more
17 Feb 2021 13:48

IN BRIEF: Open Orphan Covid Characterisation Study Gets Approval

IN BRIEF: Open Orphan Covid Characterisation Study Gets Approval

Read more
3 Feb 2021 16:28

Open Orphan opens new quarantine clinic in Whitechapel

(Sharecast News) - Pharmaceutical services contract research organisation (CRO) Open Orphan has opened a new quarantine clinic in east London, it announced on Wednesday.

Read more
3 Feb 2021 11:55

IN BRIEF: Open Orphan Launches New Quarantine Clinic In London

IN BRIEF: Open Orphan Launches New Quarantine Clinic In London

Read more
1 Feb 2021 13:20

Open Orphan renews contract with Carna Biosciences

(Sharecast News) - Pharmaceutical services clinical research organisation Open Orphan announced a further contract renewal with Carna Biosciences on Monday, extending its integrated drug development consultancy services with Open Orphan subsidiary Venn Life Sciences.

Read more
1 Feb 2021 11:54

IN BRIEF: Open Orphan Inks Contract Renewal With Carna Biosciences

IN BRIEF: Open Orphan Inks Contract Renewal With Carna Biosciences

Read more
20 Jan 2021 21:16

IN BRIEF: Open Orphan Opens Two New Volunteer Recruitment Centres

IN BRIEF: Open Orphan Opens Two New Volunteer Recruitment Centres

Read more
11 Jan 2021 15:56

Open Orphan confirms first volunteer dosing of needle-free Covid vaccine

(Sharecast News) - Specialist pharmaceutical services contract research organisation Open Orphan announced on Monday that the first volunteer had been dosed with the Codagenix needle-free intranasal Covid-19 vaccine, 'COVI-VAC'.

Read more
11 Jan 2021 11:45

Open Orphan Doses First Volunteer In Needle Free Covid Vaccine Trial

Open Orphan Doses First Volunteer In Needle Free Covid Vaccine Trial

Read more
6 Jan 2021 14:37

IN BRIEF: Open Orphan Inks Contract Renewal With Top-3 Pharma Client

IN BRIEF: Open Orphan Inks Contract Renewal With Top-3 Pharma Client

Read more
23 Dec 2020 19:50

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

Read more
22 Dec 2020 14:26

IN BRIEF: Open Orphan Pens Contract Extension With Major Client

IN BRIEF: Open Orphan Pens Contract Extension With Major Client

Read more
22 Dec 2020 10:44

Open Orphan renews contract with top-3 pharma client

(Sharecast News) - Pharmaceutical services contract research organisation Open Orphan announced a contract renewal on Tuesday, extending its consultancy services with an unnamed "major top-three global" pharmaceutical client to December 2021.

Read more
14 Dec 2020 22:04

UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid

UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.